Publisher Correction to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival

Annals of Nuclear Medicine, Jun 2018

Aatif Parvez, Noam Tau, Douglas Hussey, Manjula Maganti, Ur Metser

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs12149-018-1271-y.pdf

Publisher Correction to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival

Annals of Nuclear Medicine and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival Aatif Parvez 0 1 Noam Tau 0 1 Douglas Hussey 0 1 Manjula Maganti 0 1 Ur Metser 0 1 Ur Metser 0 1 0 Department of Biostatistics, Princess Margaret Cancer Centre , Toronto , Canada 1 Joint Department of Medical Imaging, Princess Margaret Cancer Centre, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto , 610 University Ave, Suite 3-960, Toronto, ON M5G 2M9 , Canada Owing to an unfortunate mistake at Springer's end, the title was incorrectly published as “718F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive nonHodgkin's lymphoma as predictors of treatment outcome and survival”. The correct title is given in this correction. The original article was corrected.


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs12149-018-1271-y.pdf

Aatif Parvez, Noam Tau, Douglas Hussey, Manjula Maganti, Ur Metser. Publisher Correction to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin’s lymphoma as predictors of treatment outcome and survival, Annals of Nuclear Medicine, 2018, 417-417, DOI: 10.1007/s12149-018-1271-y